Schedule 13G ownership disclosure
Olema Pharmaceuticals Inc
Security class unavailable · CUSIP: 68062P106
Event date: 2024-12-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-275608
- Form type
- SC 13G
- Filer
- Bain Capital Life Sciences Opportunities IV, L.P.
- CIK
- CIK 2015553
- Filed
- Dec 11, 2024
- Reporting period
- Dec 04, 2024
- Description
- Schedule 13G beneficial ownership